The David Rubenstein Show
Vas Narasimhan
Mar 7, 2024
Novartis CEO Vas Narasimhan discusses transforming the company into an innovative medicines giant. Topics include pharmaceutical innovations, AI in drug research, sustainability efforts, diversity & inclusion, and essential skills for CEOs. Insights on career growth in the pharmaceutical industry and market investment opportunities.
23:48
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Constant innovation is crucial in the pharmaceutical industry due to patent expiration and the need to develop new medications.
- Novartis is focused on advancing RNA therapeutics, cell therapy, and radioligand therapy to revolutionize healthcare treatments.
Deep dives
Key Products at Novartis
Novartis produces several major drugs like Entrusto for heart failure, Cosentix for immunology indications, and Kiskali for breast cancer, among others. These medicines contribute to over 15 products with sales exceeding a billion dollars, showcasing Novartis' extensive pharmaceutical portfolio.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
